西班牙加泰罗尼亚2010-2024年200万儿童青少年哮喘发病率和患病率趋势:一项基于人群的队列研究
结果显示粗发病率为687.46/10万人年,发病率在男性、低龄及最贫困地区人群中更高,新冠疫情期间急剧下降后5-14岁儿童发病率回升,患病率至2019年上升后趋稳,2024年为7.36%。
要点
- 哮喘粗发病率为687.46/10万人年,男性、1-4岁儿童及最贫困地区人群发病率更高。
- 发病率在新冠疫情期间急剧下降,疫情后5-14岁儿童回升,但1-4岁儿童持续下降。
- 患病率至2019年呈上升趋势后趋稳,2024年患病率为7.36%。
核心结论
- 儿童青少年哮喘仍是重要公共卫生负担,发病率和患病率随年龄、性别和社会经济状况而异,需持续监测以指导预防。
研究设计与样本
- 通过SNOMED代码确定哮喘诊断,估算年发病率和患病率,并按性别、年龄和社会经济剥夺指数分层分析。
- 使用Joinpoint模型分析发病率时间趋势。
主要发现
- 2010-2024年哮喘粗发病率为687.46/10万人年(95%CI 683.09-691.85)。
- 男性发病率高于女性(IRR=1.35,95%CI 1.33-1.37),但青春期后模式反转。
- 1-4岁儿童发病率高于15-17岁(IRR=3.03,95%CI 2.96-3.11)。
- 最贫困地区人群发病率高于最不贫困五分位(IRR=1.14,95%CI 1.11-1.16)。
- 发病率在新冠前下降、疫情期间急剧下降、疫情后5-14岁儿童回升而1-4岁儿童持续下降;患病率至2019年上升后趋稳,2024年为7.36%(7.3%-7.41%)。
临床怎么用
- 关注男性、低龄儿童及社会经济剥夺程度高的人群,作为哮喘预防和管理的重点对象。
- 疫情期间及后疫情时代哮喘发病率变化提示需持续监测儿童哮喘流行病学趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Asthma represents a major public health concern in childhood and adolescence. However, population-based estimates of trends in its epidemiology in Spain are limited. METHODS: We conducted a population-based cohort study using primary care electronic health records in Catalonia, Spain, from 2010 to 2024. Asthma diagnoses, ascertained through Systematized Nomenclature of Medicine (SNOMED) codes, were leveraged to estimate annual incidence rates (IR) and prevalence among children aged 1-17 years. Results were stratified by sex, age and Socioeconomic Deprivation Index (SDI). Incidence rate ratios (IRR) were estimated to investigate differences in overall incidence of asthma in these sociodemographic groups. Joinpoint modelling was used to investigate time trends in incidence. RESULTS: We included 2 001 625 individuals (48.40% females, median age 7 years). Crude IR of asthma (2010-2024) was 687.46 (95% CI 683.09 to 691.85) per 100 000 person-years. Incidence was highest in males (IRR=1.35, 95% CI 1.33 to 1.37, vs females) until adolescence, after which the pattern reversed, youngest individuals (IRR=3.03 95% CI 2.96 to 3.11, for 1-4 versus 15-17) and in individuals living in the most deprived areas (IRR=1.14, 95% CI 1.11 to 1.16, vs least deprived SDI quintile). Incidence declined before the COVID-19 pandemic, dropped sharply during it, and then increased among children aged 5-14 years post-pandemic, while consistently decreased in children aged 1-4 years. Asthma prevalence showed an upward trend until 2019 followed by stabilisation until 2024, when its prevalence was 7.36% (7.3%-7.41%). CONCLUSION: Asthma remains a major public health burden in children and adolescents, with incidence and prevalence varying by age, sex and socioeconomic status, making continuous monitoring essential to guide prevention.
引用
- Palomar-Cros A, Abellan A, Raventós B, et al. Trends in asthma incidence and prevalence in 2 million children and adolescents in Catalonia, Spain, 2010-2024: a population-based cohort study. Thorax. 2026. PMID: 42259635. doi:10.1136/thorax-2026-224985
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。